Hepatitis C Virus and Liver Disease: Global Transcriptional Profiling and Identification of Potential Markers

Hepatology

Volumn 38, Issue 6, 2003, Pages 1458-1467

  Smith, Maria W ^a,c   Yue, Zhaoxia N ^a   Korth, Marcus J ^a   Do, Hao A ^a   Boix, Loreto ^a   Fausto, Nelson ^b   Bruix, Jordi ^a   Carithers Jr , Robert L ^a   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LIVER CIRRHOSIS; MICROANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

EID: 0344155169     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hep.2003.09.024     Document Type: Article

References (38)

1. Alter HJ, Seeff LB. Recovery, persistence and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000;20:17-35.
2. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-472.
3. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepatitis C. HEPATOLOGY 2001;33:196-200.
4. Branch AD, Walewski JL. The coming impact of gene expression profiling on the diagnosis and treatment of HCV-associated liver disease. Antiviral Res 2001;52:173-179.
5. Shackel NA, Gorrell MD, McCaughan GW. Gene array analysis and the liver. HEPATOLOGY 2002;36:1313-1325.
6. Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001;120:955-966.
7. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut 2001;49:565-576.
8. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 2002;160:641-654.
9. Pritchard CC, Hsu L, Delrow J, Nelson PS. Project normal: defining normal variation in mouse gene expression. Proc Natl Acad Sci U S A 2001;98:13266-13271.
10. Yano N, Habib NA, Fadden KJ, Yamashita H, Mitry R, Jauregui H, Kane A, et al. Profiling the adult human liver transcriptome: analysis by cDNA array hybridization. J Hepatol 2001;35:178-186.
11. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. HEPATOLOGY 2002;35:519-524.
12. Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, Lazaro CA, et al. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003;63:859-864.
13. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, et al. Minimum information about a microarray experiment (MIAME) toward standards for microarray data. Nat Genet 2001;29:365-371.
14. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 1999;285:1390-1393.
15. Christoffels VM, Sassi H, Ruijter JM, Moorman AF, Grange T, Lamers WH. A mechanistic model for the development and maintenance of portocentral gradients in gene expression in the liver. HEPATOLOGY 1999;29:1180-1192.
16. Erhardt A, Hassan M, Heintges T, Haussinger D. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002;292:272-284.
17. Eng FJ, Friedman SL. Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol 2000;279:G7-G11.
18. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002;36:200-209.
19. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
20. Lang A, Schrum LW, Schoonhoven R, Tuvia S, Solis-Herruzo JA, Tsukamoto H, Brenner DA, et al. Expression of small heat shock protein alphaB-crystallin is induced after hepatic stellate cell activation. Am J Physiol 2000;279:G1333-G1342.
21. Cassiman D, Roskams T, van Pelt J, Libbrecht L, Aertsen P, Crabbe T, Vankelecom H, et al. Alpha B-crystallin expression in human and rat hepatic stellate cells. J Hepatol 2001;35:200-207.
22. Weiskirchen R, Moser M, Weiskirchen S, Erdel M, Dahmen S, Buettner R, Gressner AM. LIM-domain protein cyst. Biochem J 2001;359:485-496.
23. Rojkind M. Fibrogenesis in cirrhosis. Potential for therapeutic intervention. Pharmacol Ther 1992;53:81-104.
24. Lalor PF, Shields P, Grant A, Adams DH. Recruitment of lymphocytes to the human liver. Immunol Cell Biol 2002;80:52-64.
25. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002;1572:263-273.
26. Fillon S, Klingel K, Warntges S, Sauter M, Gabrysch S, Pestel S, Tanneur V, et al. Expression of the serine/threonine kinase hSGK 1 in chronic viral hepatitis. Cell Physiol Biochem 1903;12:47-54.
27. Brunner D. How to grab a microtubule on the move. Dev Cell 2002;3:2-4.
28. Fukata M, Kaibuchi K. Rho-family GTPases in cadherin-mediated cell-cell adhesion. Nat Rev Mol Cell Biol 2001;2:887-897.
29. Pirone DM, Fukuhara S, Gutkind JS, Burbelo PD. SPECs, small binding proteins for Cdc42. J Biol Chem 2000;275:22650-22656.
30. Welsh CF, Assoian RK. A growing role for Rho family GTPases as intermediaries in growth factor- and adhesion-dependent cell cycle progression. Biochim Biophys Acta 2000;1471:M21-M29.
31. Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. HEPATOLOGY 2003;37:87-95.
32. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-1911.
33. Belov GA, Romanova LI, Tolskaya EA, Kolesnikova MS, Lazebnik YA, Agol VI. The major apoptotic pathway activated and suppressed by poliovirus. J Virol 2003;77:45-56.
34. Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, Katze MG. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 2001;75:4321-4331.
35. Geiss G, Ge J, Guo J, Bumgarner R, Katze MG, Sen GC. A comprehensive view of gene expression by double-stranded RNA-mediated cell signaling. J Biol Chem 2001;276:30178-30182.
36. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A 2002;99:10736-10741.
37. Lanford RE, Bigger C. Advances in model systems for hepatitis C virus research. Virology 2002;293:1-9.
38. Patzwahl R, Meier V, Ramadori G, Mihm S. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol 2001;75:1332-1338.